Structure Therapeutics IncNASDAQ:GPCR
- LAST PRICE37.7500
- TODAY'S CHANGE (%)1.3800 (3.7943%)
- Bid / Lots34.8000/ 3
- Ask / Lots38.9100/ 5
- Open / Previous Close36.0000 / 36.3700
- Day Range
- 52 Week Range
- Volume1,160,389
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GPCR |
|---|---|---|
| 09:32 ET | 14932 | 35.22 |
| 09:33 ET | 7183 | 34.524 |
| 09:35 ET | 11168 | 34.7527 |
| 09:37 ET | 14305 | 34.1 |
| 09:39 ET | 15609 | 34.3844 |
| 09:42 ET | 8849 | 35.215 |
| 09:44 ET | 33463 | 34.89 |
| 09:46 ET | 8528 | 34.77 |
| 09:48 ET | 3300 | 34.97 |
| 09:50 ET | 22403 | 34.73 |
| 09:51 ET | 65927 | 35.39 |
| 09:53 ET | 4087 | 35.76 |
| 09:55 ET | 1350 | 36.07 |
| 09:57 ET | 4194 | 36.44 |
| 10:00 ET | 950 | 36.37 |
| 10:02 ET | 1300 | 36.3 |
| 10:04 ET | 1498 | 36.05 |
| 10:06 ET | 4178 | 36.16 |
| 10:08 ET | 608 | 36.15 |
| 10:09 ET | 618 | 36.085 |
| 10:11 ET | 2803 | 36.2 |
| 10:13 ET | 3630 | 36.46 |
| 10:15 ET | 2805 | 36.465 |
| 10:18 ET | 20386 | 37.265 |
| 10:20 ET | 3930 | 37 |
| 10:22 ET | 1400 | 37.05 |
| 10:24 ET | 1400 | 37.2 |
| 10:26 ET | 4867 | 37.22 |
| 10:27 ET | 3620 | 37.07 |
| 10:29 ET | 1598 | 37.3 |
| 10:31 ET | 300 | 37.28 |
| 10:33 ET | 1680 | 37.21 |
| 10:36 ET | 102483 | 37.13 |
| 10:38 ET | 1600 | 36.77 |
| 10:40 ET | 2157 | 36.64 |
| 10:42 ET | 856 | 36.95 |
| 10:44 ET | 1050 | 37 |
| 10:45 ET | 6357 | 37.125 |
| 10:47 ET | 1002 | 36.94 |
| 10:49 ET | 1270 | 36.78 |
| 10:51 ET | 1850 | 36.84 |
| 10:54 ET | 400 | 36.67 |
| 10:56 ET | 2936 | 36.5 |
| 10:58 ET | 500 | 36.455 |
| 11:00 ET | 500 | 36.27 |
| 11:02 ET | 2240 | 36.43 |
| 11:03 ET | 2350 | 36.49 |
| 11:05 ET | 800 | 36.307 |
| 11:09 ET | 1000 | 36.04 |
| 11:12 ET | 2324 | 36.39 |
| 11:14 ET | 2000 | 36.28 |
| 11:16 ET | 9334 | 36.24 |
| 11:18 ET | 2244 | 36.49 |
| 11:20 ET | 977 | 36.66 |
| 11:21 ET | 1979 | 36.68 |
| 11:25 ET | 735 | 36.3 |
| 11:27 ET | 400 | 36.24 |
| 11:30 ET | 2564 | 36.42 |
| 11:32 ET | 11051 | 36.0364 |
| 11:34 ET | 13375 | 35.85 |
| 11:38 ET | 237 | 35.91 |
| 11:39 ET | 400 | 35.95 |
| 11:41 ET | 100 | 35.995 |
| 11:43 ET | 1091 | 36.07 |
| 11:45 ET | 320 | 36.005 |
| 11:48 ET | 11145 | 36.345 |
| 11:50 ET | 200 | 36.6334 |
| 11:52 ET | 16337 | 36.465 |
| 11:54 ET | 835 | 36.29 |
| 11:56 ET | 200 | 36.325 |
| 11:57 ET | 15395 | 36.595 |
| 11:59 ET | 750 | 36.53 |
| 12:01 ET | 1153 | 36.68 |
| 12:03 ET | 3205 | 36.88 |
| 12:06 ET | 212 | 36.87 |
| 12:08 ET | 5844 | 37.2126 |
| 12:10 ET | 323 | 37.3899 |
| 12:14 ET | 100 | 37.25 |
| 12:15 ET | 9168 | 36.98 |
| 12:17 ET | 3366 | 37.11 |
| 12:19 ET | 656 | 37.16 |
| 12:21 ET | 100 | 37.17 |
| 12:24 ET | 3450 | 37.06 |
| 12:26 ET | 1677 | 37.1 |
| 12:32 ET | 300 | 37.29 |
| 12:33 ET | 400 | 37.0202 |
| 12:35 ET | 1100 | 37.0148 |
| 12:37 ET | 9108 | 37.0175 |
| 12:39 ET | 1200 | 36.96 |
| 12:42 ET | 500 | 36.95 |
| 12:44 ET | 526 | 36.78 |
| 12:46 ET | 200 | 36.58 |
| 12:48 ET | 300 | 36.75 |
| 12:50 ET | 512 | 36.7 |
| 12:51 ET | 984 | 36.825 |
| 12:53 ET | 300 | 36.75 |
| 12:55 ET | 990 | 36.805 |
| 12:57 ET | 995 | 36.88 |
| 01:00 ET | 250 | 36.88 |
| 01:02 ET | 100 | 36.895 |
| 01:04 ET | 400 | 36.91 |
| 01:06 ET | 1700 | 37 |
| 01:08 ET | 100 | 37 |
| 01:15 ET | 113 | 36.9 |
| 01:20 ET | 200 | 36.9061 |
| 01:22 ET | 400 | 36.99 |
| 01:26 ET | 3633 | 37.18 |
| 01:27 ET | 3144 | 37.38 |
| 01:29 ET | 1524 | 37.29 |
| 01:31 ET | 10631 | 37.54 |
| 01:33 ET | 5802 | 37.65 |
| 01:36 ET | 3149 | 37.881 |
| 01:38 ET | 4067 | 37.77 |
| 01:40 ET | 500 | 37.85 |
| 01:42 ET | 715 | 37.8425 |
| 01:44 ET | 1734 | 37.96 |
| 01:45 ET | 13688 | 38.06 |
| 01:47 ET | 1307 | 37.95 |
| 01:49 ET | 1182 | 37.7399 |
| 01:51 ET | 701 | 38.05 |
| 01:54 ET | 4217 | 38 |
| 01:56 ET | 3411 | 37.96 |
| 01:58 ET | 1487 | 37.915 |
| 02:00 ET | 600 | 37.915 |
| 02:02 ET | 800 | 37.82 |
| 02:03 ET | 724 | 37.81 |
| 02:05 ET | 8073 | 37.575 |
| 02:07 ET | 513 | 37.3808 |
| 02:09 ET | 200 | 37.26 |
| 02:12 ET | 1007 | 37.15 |
| 02:14 ET | 300 | 37.15 |
| 02:16 ET | 465 | 37.17 |
| 02:18 ET | 2328 | 37.06 |
| 02:20 ET | 200 | 37.12 |
| 02:21 ET | 846 | 37.1 |
| 02:23 ET | 300 | 37.05 |
| 02:25 ET | 4705 | 37.595 |
| 02:27 ET | 300 | 37.68 |
| 02:30 ET | 461 | 37.68 |
| 02:32 ET | 300 | 37.84 |
| 02:34 ET | 1275 | 37.73 |
| 02:36 ET | 825 | 37.78 |
| 02:38 ET | 6715 | 37.855 |
| 02:39 ET | 900 | 37.78 |
| 02:41 ET | 600 | 37.68 |
| 02:43 ET | 300 | 37.84 |
| 02:45 ET | 7822 | 37.93 |
| 02:48 ET | 4708 | 37.92 |
| 02:50 ET | 1355 | 37.925 |
| 02:52 ET | 763 | 37.92 |
| 02:54 ET | 4753 | 37.98 |
| 02:56 ET | 3228 | 38.025 |
| 02:57 ET | 4557 | 38.36 |
| 02:59 ET | 400 | 38.4 |
| 03:01 ET | 4105 | 38.195 |
| 03:03 ET | 652 | 38.07 |
| 03:06 ET | 1151 | 38.12 |
| 03:08 ET | 4877 | 38.1606 |
| 03:10 ET | 400 | 38.14 |
| 03:12 ET | 3846 | 38.13 |
| 03:14 ET | 2691 | 38.245 |
| 03:15 ET | 5000 | 38.13 |
| 03:17 ET | 1385 | 38.26 |
| 03:19 ET | 3321 | 38.235 |
| 03:21 ET | 1529 | 38.12 |
| 03:24 ET | 757 | 38.27 |
| 03:26 ET | 4355 | 38.19 |
| 03:28 ET | 1920 | 38.09 |
| 03:30 ET | 3112 | 38.3335 |
| 03:32 ET | 300 | 38.22 |
| 03:33 ET | 6723 | 37.97 |
| 03:35 ET | 2044 | 38.16 |
| 03:37 ET | 3648 | 38.075 |
| 03:39 ET | 6232 | 37.97 |
| 03:42 ET | 3421 | 38.04 |
| 03:44 ET | 6233 | 37.5 |
| 03:46 ET | 1800 | 37.71 |
| 03:48 ET | 5755 | 37.99 |
| 03:50 ET | 2496 | 37.99 |
| 03:51 ET | 11168 | 37.915 |
| 03:53 ET | 19451 | 37.82 |
| 03:55 ET | 25236 | 37.735 |
| 03:57 ET | 18253 | 37.455 |
| 04:00 ET | 80147 | 37.69 |
Nov 13, 2024
Press Release: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow JonesStructure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 13, 2024 by Dow JonesStructure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity, from 4:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
4:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
Oct 31, 2024
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek(R) 2024, from 8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
8:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Structure Therapeutics Inc | 2.1B | -16.9x | --- |
Akero Therapeutics Inc | 2.2B | -7.9x | --- |
Disc Medicine Inc | 1.9B | -15.3x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -26.7x | --- |
Geron Corp | 2.3B | -11.5x | --- |
NewAmsterdam Pharma Company NV | 2.3B | -11.1x | --- |
Company Information
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Contact Information
- Headquarters
- 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Daniel Welch
- Chief Executive Officer, Director
- Raymond Stevens
- Chief Financial Officer
- Jun Yoon
- Chief Technology Officer
- Yingli Ma
- Chief Scientific Officer
- Xichen Lin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -16.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
